1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Global EPO Biosimilars Market Outlook 2018

Global EPO Biosimilars Market Outlook 2018

  • February 2014
  • -
  • -
  • 45 pages

The biosimilars industry has been growing stupendously across the globe for the past few years. Increasing healthcare costs, major blockbuster drugs about to go off patent and rising aging population are driving this industry, which stands at a vivid position, and is expected to evolve greatly from its current state. With the governments and private players worldwide stepping into this industry, the market shows bright prospects and immense opportunities to cash in on.

As per the estimations of our latest report, “Global EPO Biosimilars Market Outlook 2018”, the global EPO biosimilars market will grow at a CAGR of around 37% during 2013-2018. Our report provides a thorough study of the EPO biosimilars market, and its future outlook. Firstly, we have provided a basic overview of the total biologics market, along with its current and future size. Next, we have highlighted some of the major trends and drivers which would be responsible for shaping the global biosimilars market. Some of these trends are rising collaborations among major pharma players and strong government support to encourage the growth of biosimilars. This is then followed by the total biosimilars market and its future size. The key segments of this market and their respective shares have also been highlighted.

Finally, we have given a brief introduction of the global EPO biosimilars market, its estimated size and future value. The market is about to witness rapid growth as a result of major blockbuster drugs losing their patents in 2013 and 2014. We have also provided a list of the marketed EPO biosimilars and those that are in the pipeline.

At the end, key players of the EPO biosimilars market have been profiled where focus has been on their business overview, key products and those in the pipeline of the companies. Overall, the report aims at providing reliable and complete information about the EPO biosimilars market to clients and potential investors.

Table Of Contents

Global EPO Biosimilars Market Outlook 2018
1. Analyst View
2. Research Methodology
3. Biologics Market Outlook to 2018
3.1 Market Size
3.2 Market Segmentation
4. Market Trends and Drivers
4.1 Emerging Markets to Play a Pivotal Role in the Growth of Biosimilars
4.2 Rising Business Alliances Aiding in Biosimilar Development
4.3 Governments Realizing the Potential in Biosimilars, Encouraging Industry Growth
5. Biosimilars Market Outlook to 2018
6. Erythropoietin Market Outlook to 2018
6.1 Scientific Insight
6.2 Market Analysis
6.3 EPO Biosimilars Products - Marketed and Under-Pipeline
7. Competitive Landscape
7.1 Hospira
7.2 Sandoz GmbH
7.3 Stada
7.4 Hexal AG
7.5 Medice Arzneimittel Pütter GmbH and Co.
7.6 Teva
7.7 LG Life Sciences
7.8 Dr. Reddy's Labs (DRL)
7.9 Biocon
7.10 Intas Pharmaceuticals
7.11 Reliance Life Sciences
7.12 3 SBio Inc

List of Figures

Figure 3-1: Global - Biologics Market (Billion US$), 2012-2018
Figure 3-2: Global - Biologics Market by Segment (%), 2012
Figure 5-1: Global - Biosimilars Market (Billion US$), 2012 and 2018
Figure 5-2: Global - Biosimilars Market by Key Segment (%), 2012
Figure 6-1: Global - EPO Biosimilars Market (Billion US$), 2012-2018
Figure 6-2: Global - EPO Biosimilar Market by Player (%), 2012

List of Tables

Table 6-1: Global - Marketed EPO Biosimilar Products of Key Players
Table 6-2: Global - Pipeline EPO Biosimilar Products of Key Players

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4 157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Global Biosimilars Industry

Global Biosimilars Industry

  • $ 4 500
  • Industry report
  • July 2016
  • by Global Industry Analysts

This report analyzes the worldwide markets for Biosimilars in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts ...

Global Biosimilars And Follow-On Biologics Market Research Report 2016

Global Biosimilars And Follow-On Biologics Market Research Report 2016

  • $ 2 850
  • Industry report
  • September 2016
  • by 9Dimen Research

2016 Global Biosimilars And Follow-On Biologics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Biosimilars And Follow-On Biologics ...

The Future Of Biosimilars 2016

July 2016 $ 2 360

Global Biosimilar Market Outlook 2022

September 2016 $ 1 500

Download Unlimited Documents from Trusted Public Sources

Biosimilar Market in the US

  • October 2016
    4 pages
  • Biosimilar  


    Clinical Trial  

  • United States  

View report >

Biosimilar Industry in the US

  • September 2016
    28 pages
  • Biosimilar  


  • United States  

View report >

Global Vaccine Industry

  • September 2016
    47 pages
  • Vaccine  



  • World  

View report >

Bioprocessing Industry

2 months ago

Biosimilar Statistics

2 months ago

Biosimilar Statistics

2 months ago

Related Market Segments :



Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.